Ad is loading...
FSPHX vs HGHTX
FSPHX vs HGHTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FSPHX vs. HGHTX commentary
Dec 19, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a StrongBuy and HGHTX is a Buy.
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 7.51B vs. HGHTX (952M). FSPHX (0.00) and HGHTX (0.00) have matching dividends . FSPHX was incepted earlier than HGHTX: FSPHX (43 years) vs HGHTX (18 years). FSPHX is a more actively managed with annual turnover of: 40.00 vs. HGHTX (32.00). FSPHX (0) and HGHTX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : 7.35 vs. HGHTX (0.46). FSPHX return over 5 years is better than : 5.20 vs. HGHTX (0.37).
| FSPHX | HGHTX | FSPHX / HGHTX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 43 years | 18 years | - |
| Gain YTD | 3.651 | -1.989 | -184% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.51B | 952M | 789% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 7.35 | 0.46 | 1,586% |
| Returns for 3 years | -4.79 | -8.50 | 56% |
| Returns for 5 years | 5.20 | 0.37 | 1,404% |
| Returns for 10 years | 34.71 | 9.11 | 381% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EDV | 71.85 | 0.51 | +0.71% |
| Vanguard Extended Duration Trs ETF | |||
| TPYP | 34.16 | -0.20 | -0.58% |
| Tortoise North American Pipeline | |||
| FJP | 51.06 | -0.35 | -0.68% |
| First Trust Japan AlphaDEX® ETF | |||
| FDCF | 39.10 | -0.30 | -0.77% |
| Fidelity Disruptive Communications ETF | |||
| CNCR | 12.66 | -0.15 | -1.20% |
| Range Cancer Therapeutics ETF | |||